Neomycin sulfate, betamethasone valerate.
Each gram cream contains: Neomycin sulfate 3.5 mg (potency), betamethasone valerate 1.2 mg (equivalent to 1 mg of betamethasone).
Neopac cream contains betamethasone valerate which is potent corticosteroid and neomycin sulfate which is aminoglycoside antibiotics.
Betamethasone valerate has potent anti-inflammatory, anti-pruritic and antiallergenic activity and Neomycin sulfate provides highly effective treatment in primary and secondary bacterial skin infections.
Allergic and inflammatory dermatitis as following: acute and chronic eczema, contact dermatitis, atopic dermatitis, seborrheic dermatitis, lichen chronicus simplex, intertrigo, exfoliative dermatitis, popular hives, psoriasis, itching (anus, vagina), solar dermatitis.
Alopecia areata, first degree burn, insect bite, dermatological disease caused by secondary bacterial infection.
Apply to the affected area, one to several times daily.
Wound, mucous membrane. Tuberculoderm, herpes simplex, varicella herpes zoster, vaccina, syphilis. Patients with a history of hypersensitivity to this preparation. Otitis external eczematous in the perforated eardrum. Patients with a history of hypersensitivity to aminoglycoside antibiotics (streptomycin, kanamycin, gentamycin, neomycin, etc.) or bacitracin.
Don't use in ophthalmic agents.
This drug contains propylene glycol, the patients with known history of hypersensitivity or allergy to propylene glycol should notify the physician or pharmacist before using.
If this drug is used with large quantity, long-term broadly use (especially occlusive dressing), the symptoms like which the corticosteroid is used in all body may occur. So avoid long-term use or occlusive dressings except in particular cases.
In case a sensitization symptom (itching, erythema, swelling, comedo, bulla, etc.) occurs, discontinue the use of this drug.
Avoid the long term use.
Discontinue the use of this drug when the symptoms are not approved or get worse.
It has been reported that use in patients with psoriasis for long time may cause erythroderma psoriasiform, pustular psoriasis in treatment or after treatment.
Use in Pregnancy: The safety of this drug to pregnant women has not been established, therefore avoid large quantity or long-term, broad use to pregnant women or women of pregnancy potential.
Skin: Long term continuous steroid therapy should be avoided since it can cause steroid acne (which has a tendency to exhibit poly whites comedone, like with acne vulgaris), steroidal skin (skin atrophy, telangiectasia), steroidal rosacea i.e. perioral dermatitis (erythema of peripheral or occasionally all face, comedo, telangiectasis, crust, etc. occur), skin change like ichthyosis, purpura, hirsutism, hypopigmentation. Such symptoms may occur, medication should be changed to non-steroid drugs with decreasing the dose of this drug slowly.
Hypersensitivity: In case of skin irritation, eruption, discontinue the therapy.
HPA axis, adrenal cortex function: Long-term continuous broad therapy, occlusive dressings may cause hypothalamic-pituitary-adrenal (HPA) axis, adrenal cortex dysfunction, so it is necessary to pay attention.
Eye: In case of use in eyelid ocular hypertension, glaucoma may occur. So it is necessary to pay attention. Long-term continuous therapy or occlusive dressings may cause cataract, glaucoma.
Bacterial alternation: Rarely, infection caused by growth of nonsusceptible bacteria may occur. At that case, discontinue the therapy.
Renal dysfunction, hardness of hearing may occur. So avoid the long-term continuous therapy.
Inform the doctor in case of any adverse reactions related to drug use.
In a tight containers, at room temperature.
Shelf-Life: 36 months from manufacturing date.
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Topical cream (white) 15 g x 1's.